Micromolar changes in lysophosphatidylcholine concentration cause minor effects on mitochondrial permeability but major alterations in function

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 6, 2014, Pages 888-895

  Hollie, Norris I ^a   Cash, James G ^a   Matlib, M Abdul ^a   Wortman, Matthew ^a   Basford, Joshua E ^a   Abplanalp, William ^a   Hui, David Y ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Hepatocyte; Lysophosphatidylcholine; Mitochondrion; Oxidation

Indexed keywords

CALCIUM CHLORIDE; CYCLOSPORIN A; CYTOCHROME C; FATTY ACID; GLUTAMIC ACID; LYSOPHOSPHATIDYLCHOLINE; MALIC ACID; PALMITOYLCARNITINE; SUCCINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL RESPIRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FATTY ACID OXIDATION; LIPID BLOOD LEVEL; LIVER CELL; LIVER MITOCHONDRION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION SWELLING; MOUSE; NONHUMAN; OXIDATION; OXYGEN CONSUMPTION; POSTPRANDIAL STATE; PRIORITY JOURNAL; RESPIRATION CONTROL;

HEPATOCYTE; LYSOPHOSPHATIDYLCHOLINE; MITOCHONDRION; OXIDATION;

ANIMALS; CALCIUM CHLORIDE; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GROUP IV PHOSPHOLIPASES A2; HEPATOCYTES; LYSOPHOSPHATIDYLCHOLINES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA, LIVER; OXIDATION-REDUCTION; PERMEABILITY;

EID: 84897459753     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2013.11.013     Document Type: Article

References (45)

1. 2 Annu. Rev. Biochem. 77 2008 495 520
2. 2 superfamily and its group numbering system Biochim. Biophys. Acta 1761 2006 1246 1259 (Pubitemid 44755364)
3. 2 gene Gene 244 2000 65 72 (Pubitemid 30109561)
4. 2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia Diabetes 55 2006 935 941 (Pubitemid 44100167)
5. O.W. Portman, P. Soltys, M. Alexander, and T. Osuga Metabolism of lysolecithin in vivo: effects of hyperlipidemia and atherosclerosis in squirrel monkeys J. Lipid Res. 11 1970 596 604
6. + ATPase activity and plasma lysophosphatidylcholine concentrations in diabetic patients Diabetes 43 1994 915 919 (Pubitemid 24196425)
7. S. Guo, X. Shi, F. Yang, L. Chen, E.J. Meehan, C. Bian, and M. Huang Structural basis of transport of lysophospholipids by human serum albumin Biochem. J. 423 2009 23 30
8. 2-deficient mice Am. J. Physiol. 283 2002 E994 E1001
9. 2 and diet-induced obesity FASEB J. 24 2010 2516 2524
10. 2 deficiency protects against diet-induced hyperlipidemia in mice J. Lipid Res. 52 2011 2005 2011
11. Z. Zhou, J. Luchoomun, A. Bakillah, and M.M. Hussain Lysophosphatidylcholine increases apolipoprotein B secretion by enhancing lipid synthesis and decreasing its intracellular degradation in HepG2 cells Biochim. Biophys. Acta 1391 1998 13 24 (Pubitemid 28143971)
12. J. Wanninger, M. Neumeier, J. Weigert, G. Liebisch, T.S. Weiss, A. Schaffler, C. Aslanidis, G. Schmitz, J. Scholmerich, and C. Buechler Metformin reduces cellular lysophosphatidylcholine and thereby may lower apolipoprotein B secretion in primary human hepatocytes Biochim. Biophys. Acta 1781 2008 321 325
13. B.S. Robinson, Z. Yao, D.J. Baisted, and D.E. Vance Lysophosphatidylcholine metabolism and lipoprotein secretion by cultured rat hepatocytes deficient in choline Biochem. J. 260 1989 207 214 (Pubitemid 19139916)
14. 2 antagonists J. Biol. Chem. 275 2000 25023 25030 (Pubitemid 30626612)
15. M.A. Matlib, W.A. Shannon, and P.A. Srere Measurement of matrix enzyme activity in situ in isolated mitochondria made permeable with toluene Methods Enzymol. 56 1979 544 550
16. J.R. Henriksen, T.L. Andresen, L.N. Feldborg, L. Duelund, and J.H. Ipsen Understanding detergent effects on lipid membranes: a model study of lysolipids Biophys. J. 98 2010 2199 2205
17. K.E. Akerman, and M.K. Wikstrom Safranine as a probe of the mitochondrial membrane potential FEBS Lett. 68 1976 191 197
18. J.E. Basford, L. Wancata, S.M. Hofmann, R.A. Silva, W.S. Davidson, P.N. Howles, and D.Y. Hui Hepatic deficiency of low density lipoprotein receptor related protein-1 reduces high density lipoprotein secretion and plasma levels in mice J. Biol. Chem. 286 2011 13079 13087
19. M.D. Brand, and D.G. Nicholls Assessing mitochondrial dysfunction in cells Biochem. J. 435 2011 297 312
20. B.G. Hill, G.A. Benavides, J.R. Lancaster Jr., S. Ballinger, L. Dell'Italia, Z. Jianhua, and V.M. Darley-Usmar Integration of cellular bioenergetics with mitochondrial quality control and autophagy Biol. Chem. 393 2012 1485 1512
21. B.R. Zelickson, G.A. Benavides, M.S. Johnson, B.K. Chacko, A. Venkatraman, A. Landar, A.M. Betancourt, S.M. Bailey, and V.M. Darley-Usmar Nitric oxide and hypoxia exacerbate alcohol-induced mitochondrial dysfunction in hepatocytes Biochim. Biophys. Acta 1807 2011 1573 1582
22. A.J. Woollacott, and P.B. Simpson High throughput fluorescence assays for the measurement of mitochondrial activity in intact human neuroblastoma cells J. Biomol. Screen. 6 2001 413 420 (Pubitemid 34052845)
23. V. Petronilli, G. Miotto, M. Canton, M. Brini, R. Colonna, P. Bernardi, and F. Di Lisa Transient and long lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence Biophys. J. 76 1999 725 734 (Pubitemid 29264555)
24. 2 + release in isolated liver mitochondria Biochim. Biophys. Acta 1304 1996 129 138 (Pubitemid 26414385)
25. N. Robinson, and L. Saunders The physical properties of lysolecithin and its sols. I. Solubilities, surface and interfacial tensions J. Pharm. Pharmacol. 10 1958 384 391
26. R.W. Schroff, C.D. Bucana, R.A. Klein, M.M. Farrell, and A.C.J. Morgan Detection of intracytoplasmic antigens by flow cytometry J. Immunol. Methods 70 1984 167 177 (Pubitemid 14111300)
27. A.E. Thumser, and D.C. Wilton The binding of natural and fluorescent lysophospholipids to wild type and mutant rat liver FA-binding protein and albumin Biochem. J. 307 1995 305 311
28. E. Oyanagi, H. Yano, Y. Kato, H. Fujita, K. Utsumi, and J. Sasaki l-carnitine suppresses oleic-acid induced membrane permeability transition of mitochondria Cell Biochem. Funct. 26 2008 778 786
29. N. Garcia, F. Correa, and E. Chavez On the role of the respiratory complex I on membrane permeability transition J. Bioenerg. Biomembr. 37 2005 17 23 (Pubitemid 40768561)
30. 2γ) attenuates calcium-induced opening of the mitochondrial permeability transition pore and resultant cytochrome c release J. Biol. Chem. 287 2012 29837 29850
31. 2 + transport Biochim. Biophys. Acta 982 1989 140 146 (Pubitemid 19159059)
32. M. Fontaine, A.F. Dessein, C. Douillard, D. Dobbelaere, M. Brivet, A. Boutron, M. Zater, K. Mention-Mulliez, A. Martin-Ponthieu, C. Vianey-Saban, G. Briand, N. Porchet, and J. Vamecq A novel mutation in CPT1a resulting in hepatic CPT deficiency JIMD Rep. 6 2012 7 14
33. 2γ prevents obesity and insulin resistance during high fat feeding by mitochondrial uncoupling and increased adipocyte fatty acid oxidation J. Biol. Chem. 285 2010 36495 36510
34. W.S. Lagakos, A.M. Gajda, L. Agellon, B. Binas, V. Choi, B. Mandap, T. Russnak, Y.X. Zhou, and J. Storch Different functions of intestinal and liver-type fatty acid binding proteins in intestine and in whole body energy homeostasis Am. J. Physiol. Gastrointest. Liver Physiol. 300 2011 G803 G814
35. Y.L. Kim, Y.J. Im, N.C. Ha, and D.S. Im Albumin inhibits cytotoxic activity of lysophosphatidylcholine by direct binding Prostaglandins Other Lipid Mediat. 83 2007 130 138
36. B.S. Robinson, D.J. Baisted, and D.E. Vance Comparison of albumin-mediated release of lysophosphatidylcholine and lysophosphatidylethanolamine from cultured rat hepatocytes Biochem. J. 264 1989 125 131 (Pubitemid 19283510)
37. K. Kakisaka, S.C. Cazanave, C.D. Fingas, M.E. Guicciardi, S.F. Bronk, N.W. Werneburg, J.L. Mott, and G.J. Gores Mechanisms of lysophosphatidylcholine- induced hepatocyte lipoapoptosis Am. J. Physiol. Gastrointest. Liver Physiol. 302 2012 G77 G84
38. M.S. Han, S.Y. Park, K. Shinzawa, S. Kim, K.W. Chung, J.-H. Lee, C.H. Kwon, K.-W. Lee, J.-H. Lee, C.K. Park, W.J. Chung, J.S. Hwang, J.-J. Yan, D.-K. Song, Y. Tsujimoto, and M.-S. Lee Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes J. Lipid Res. 49 2008 84 97
39. M.S. Han, Y.-M. Lim, W. Quan, J.R. Kim, K.W. Chung, M. Kang, S. Kim, S.Y. Park, J.-S. Han, S.-Y. Park, H.G. Cheon, S. Dal Rhee, T.-S. Park, and M.-S. Lee Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance J. Lipid Res. 52 2011 1234 1246
40. H. Kaneto, Y. Nakatani, D. Kawamori, T. Miyatsuka, and T.A. Matsuoka Involvement of oxidative stress and the JNK pathway in glucose toxicity Rev. Diabet. Stud. 1 2004 165 174
41. X. Fang, S. Gibson, M. Flowers, T. Furui, R.C.J. Best, and G.B. Mills Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity J. Biol. Chem. 272 1997 13683 13689 (Pubitemid 27224802)
42. H.S. Camp, S.R. Tafuri, and T. Leff c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity Endocrinology 140 1999 392 397 (Pubitemid 29011184)
43. K. Wouters, P.J. van Gorp, V. Bieghs, M.J. Gijbels, H. Duimel, D. Lutjohann, A. Kerksiek, R. van Kruchten, N. Maeda, B. Staels, M. van Bilsen, R. Shiri-Sverdlov, and M.H. Hofker Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis Hepatology 48 2008 474 486
44. N. Watanabe, J.W. Zmijewski, W. Takabe, M. Umezu-Goto, C. Le Goffe, A. Sekine, A. Landar, A. Watanabe, J. Aoki, H. Arai, T. Kodama, M.P. Murphy, R. Kalyanaraman, V.M. Darley-Usmar, and N. Noguchi Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells Am. J. Pathol. 168 2006 1737 1748
45. 2 inhibitor methyl indoxam suppresses diet-induced obesity and glucose intolerance in mice Br. J. Pharmacol. 157 2009 1263 1269 Diseases